TREM2 in the pathogenesis of AD: a lipid metabolism regulator and potential metabolic therapeutic target

Triggering receptor expressed on myeloid cells 2 (TREM2) is a single-pass transmembrane immune receptor that is mainly expressed on microglia in the brain and macrophages in the periphery. Recent studies have identified TREM2 as a risk factor for Alzheimer’s disease (AD). Increasing evidence has sho...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Rui-Yang, Qin, Qi, Yang, Han-Chen, Wang, Ying-Ying, Mi, Ying-Xin, Yin, Yun-Si, Wang, Meng, Yu, Chao-Ji, Tang, Yi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166437/
https://www.ncbi.nlm.nih.gov/pubmed/35658903
http://dx.doi.org/10.1186/s13024-022-00542-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9166437/
https://www.ncbi.nlm.nih.gov/pubmed/35658903
http://dx.doi.org/10.1186/s13024-022-00542-y

Ejemplares similares